Posted on August 17, 2021 |
By 340B Matters At long last, four top pharmaceutical companies are being sued under federal antitrust law for conspiring to deprive safety-net healthcare providers of lower pricing under the 340B ...
Posted on July 29, 2021 |
By 340B Matters The 340B Drug Discount Program is getting robbed daily by insurers and pharmacy benefit managers. Finally, someone in Washington is doing something about it. A new bill ...
Posted on July 19, 2021 |
By 340B Matters German drug giant Boehringer Ingelheim has unwisely joined an ignominious group of manufacturers attacking the 340B Drug Discount Program. The result will be even less resources for ...
Posted on July 1, 2021 |
By 340B Matters In the complex drug-pricing marketplace lies a murky underworld of pharmacy benefit managers (PBMs). Ostensibly, these companies negotiate lower drug pricing for insurers and (ideally) patients. They’...
Posted on June 18, 2021 |
By 340B Matters In July 2020, six huge drug companies fired the first salvo in a war against a federal program that helps safety-net healthcare providers care for the underserved. Their ...